SYHA136

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSYHA136
Drug Alias NameSYHA-136
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous ThrombosisVenous Thromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Active IndicationsVenous Thromboembolism
Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A